Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Oct 30;18(21):11451.
doi: 10.3390/ijerph182111451.

Diagnostic Accuracy of SARS-CoV-2 Antigen Tests for Community Transmission Screening: A Systematic Review and Meta-Analysis

Cheng-Chieh Chen  1   2 , Shou-Cheng Lu  3 , Chyi-Huey Bai  4 , Pei-Yu Wang  3 , Kang-Yun Lee  5   6 , Yuan-Hung Wang  1   7
Affiliations
Meta-Analysis

Diagnostic Accuracy of SARS-CoV-2 Antigen Tests for Community Transmission Screening: A Systematic Review and Meta-Analysis

Cheng-Chieh Chen et al. Int J Environ Res Public Health. .

Abstract

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) caused the global pandemic of coronavirus disease 2019 (COVID-19). Rapid identification and isolation of infectious patients are critical methods to block COVID-19 transmission. Antigen tests can contribute to prompt identification of infectious individuals. This meta-analysis aims to evaluate the diagnostic accuracy of antigen tests for SARS-CoV-2. We conducted a literature search in PubMed, Embase, the Cochrane Library, and Biomed Central databases. Studies evaluating the diagnostic accuracy of antigen tests for SARS-CoV-2 in community participants were included. Only English-language articles were reviewed. We included eligible studies that provided available data to construct a 2 × 2 table on a per-patient basis. Overall sensitivity and specificity for antigen tests were generated using a bivariate random-effects model. Eighteen studies with 34,865 participants were retrieved. The meta-analysis for SARS-CoV-2 antigen tests generated a pooled sensitivity of 0.82 and a pooled specificity of 1.00. A subgroup analysis of ten studies that reported outcomes for 5629 symptomatic participants generated a pooled sensitivity of 0.87 and a pooled specificity of 1.00. Antigen tests might have higher sensitivity in detecting SARS-CoV-2 in symptomatic patients in the community and may be an effective tool to identify patients to be quarantined to prevent further SARS-CoV-2 transmission.

Keywords: COVID-19; SARS-CoV-2; antigen test; meta-analysis; sensitivity and specificity.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of literature search.
Figure 2
Figure 2
SROC curve showing the pooled sensitivity and specificity of antigen test for SARS-CoV-2.
Figure 3
Figure 3
Risk of bias of individual studies. Circles of the SROC plot in MetaDTA are displayed as pie charts summarizing the risk of bias of individual studies based on the QUADAS-2 tool. The first quadrant of a circle represents patient selection, the second quadrant represents the index test, the third quadrant represents the reference standard, and the fourth quadrant represents flow and timing. Circles on the SROC plot are colored depending on their quality assessment score: green for low, red for high, and gray for unclear risk of bias.
See this image and copyright information in PMC

References

    1. Johansson M.A., Quandelacy T.M., Kada S., Prasad P.V., Steele M., Brooks J.T., Slayton R.B., Biggerstaff M., Butler J.C. SARS-CoV-2 Transmission From People Without COVID-19 Symptoms. JAMA Netw. Open. 2021;4:e2035057. doi: 10.1001/jamanetworkopen.2020.35057. - DOI - PMC - PubMed
    1. Liu Y., Morgenstern C., Kelly J., Lowe R., CMMID COVID-19 Working Group. Jit M. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. 2021;19:40. doi: 10.1186/s12916-020-01872-8. - DOI - PMC - PubMed
    1. Oran D.P., Topol E.J. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann. Intern. Med. 2020;173:362–367. doi: 10.7326/M20-3012. - DOI - PMC - PubMed
    1. Watson J., Whiting P.F., Brush J.E. Interpreting a COVID-19 test result. BMJ. 2020;369:m1808. doi: 10.1136/bmj.m1808. - DOI - PubMed
    1. Lieberman J.A., Pepper G., Naccache S.N., Huang M.L., Jerome K.R., Greninger A.L. Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories. J. Clin. Microbiol. 2020;58:e00821-20. doi: 10.1128/JCM.00821-20. - DOI - PMC - PubMed

Publication types

LinkOut - more resources